The Fellowship of Postgraduate Medicine is pleased to announce the appointment from 1st August 2015 of Professor Bernard Cheung as the next Editor-in-Chief of the Postgraduate Medical Journal, which is published on behalf of the FPM by the BMJ publishing house.
Professor Cheung said: “The PMJ has a long and illustrious history. I would like to see it go from strength to strength. I have two main aims: to make the journal interesting and useful both to recent graduates and to established health professionals; and by publishing articles on the state-of-the-art care of common diseases, to make the PMJ also appeal to a broad range of readers, including the informed general public, and journalists who are looking for authoritative up-to-date information.
The FPM expresses its grateful recognition and thanks to the outgoing Editor-in-Chief Dr Fiona Moss for all her efforts over the past 8 years to nurture and develop the PMJ.
Professor Cheung has wide experience in senior roles of editing national and international journals. His main research interest is in cardiovascular diseases and risk factors, such as hypertension and the metabolic syndrome. He is a principal investigator of the Hong Kong Cardiovascular Risk Factor Prevalence Study. He is ranked among the top 1% of researchers in his field.
Professor Cheung is the Sun Chieh Yeh Heart Foundation Professor in Cardiovascular Therapeutics and heads the Division of Clinical Pharmacology and Therapeutics in the Department of Medicine of the University of Hong Kong. Professor Cheung is an Honorary Consultant Physician of Queen Mary Hospital and the Medical Director of the Phase 1 Clinical Trials Centre. He is also the Director of the Institute of Cardiovascular Science and Medicine, and the President of the Hong Kong Pharmacology Society.
Professor Cheung read Medicine at Magdalene College, Cambridge. He was a British Heart Foundation Junior Research Fellow at Cambridge before taking up lectureships at the University of Sheffield and the University of Hong Kong. In 2007-2009, he held the chair in Clinical Pharmacology and Therapeutics at the University of Birmingham, England.